Pharming’s Leniolisib On Track To Become First Disease-Modifying APDS Drug

Following NDA Acceptance

Lots of people standing on red background, one person standing on cream background, represents standing out
Pharming Seems To Be The Only Firm Working On A Drug For APDS • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip